High-Dose HMG-CoA Inhibitor Simvastatin for Patients With Relapsed CLL: Pilot Trial and Pharmacokinetic-Pharmacodynamic Studies.
Phase of Trial: Phase I
Latest Information Update: 23 May 2014
At a glance
- Drugs Simvastatin (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Pharmacodynamics; Pharmacogenomic; Pharmacokinetics; Therapeutic Use
- 14 Nov 2013 Planned end date changed from 1 Mar 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 17 Jul 2012 Planned end date changed from 1 Mar 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
- 23 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.